Holen Sie sich die Stockscreener-App
52.21
7.22%
-4.06
Schlusskurs vom Vortag:
$56.27
Offen:
$56.27
24-Stunden-Volumen:
1.18M
Relative Volume:
1.00
Marktkapitalisierung:
$1.55B
Einnahmen:
$442.68M
Nettoeinkommen (Verlust:
$-77.81M
KGV:
-19.57
EPS:
-2.6684
Netto-Cashflow:
$-28.65M
1W Leistung:
+0.42%
1M Leistung:
+51.29%
6M Leistung:
-67.16%
1J Leistung:
-24.52%
1-Tages-Spanne:
$51.84
$56.29
1-Wochen-Bereich:
$49.49
$57.15
52-Wochen-Spanne:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
52.21 | 1.67B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - GuruFocus
WGS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - TMX Newsfile
GeneDx Holdings (WGS) Valuation After Q1 2026 Earnings Miss Guidance Cut And Legal Scrutiny - Yahoo Finance
From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading - MarketBeat
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure ... - Hastings Tribune
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm - The AI Journal
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
WGS INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of GeneDx Holdings Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm - The Killeen Daily Herald
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Dr - GuruFocus
GeneDx Holdings (WGS) Is Up 12.2% After Deep Guidance Cut And Fabric ImpairmentWhat's Changed - simplywall.st
WGS INVESTOR ACTION: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - TMX Newsfile
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics AcquisitionHagens Berman - PR Newswire
2026-06-05 | WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:WGS | Press Release - Stockhouse
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit - The Malaysian Reserve
GeneDx shares plunge 49% after missing earnings and cutting 2026 guidance, triggering securities fraud lawsuit. - Pluang
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Investor Notice: Robbins LLP Informs Investors of the GeneDx Holdings Corp. Class Action Lawsuit - The National Law Review
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS - Morningstar
DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - 巴士的報
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings - GlobeNewswire
GeneDx shares plunge 49% after huge Q1 loss and slashed 2026 revenue forecast - Pluang
GeneDx (WGS) CFO Kevin Feeley sells shares to cover RSU tax - Stock Titan
Corvex management buys GeneDx (WGS) shares worth $13.4 million By Investing.com - Investing.com Nigeria
Genedx Holdings Corp stock hits all-time high of 52.27 USD - Investing.com Nigeria
Genedx Holdings Corp stock hits all-time high of 52.27 USD By Investing.com - Investing.com South Africa
WGS Technical Analysis & Stock Price Forecast - Intellectia AI
WGS stock slumps after hours as firm predicts lower test volume for year - MSN
WGS Stock Chart | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over D - GuruFocus
Why GeneDX stock is plummeting today - MSN
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - AOL.com
(WGS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
WGS Technical Analysis | Trend, Signals & Chart Patterns | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
GeneDx shares plunge 49% after Q1 earnings miss and lowered 2026 guidance sparks legal probe - Pluang
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny - GlobeNewswire
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative – Hagens Berman - GlobeNewswire Inc.
Goldman Sachs health conference in Miami to feature GeneDx talk - Stock Titan
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Yahoo Finance
GeneDx a new overweight at Piper Sandler on rare diseases testing market - MSN
Prosight Management Acquires $42.72 Million Stake in GeneDx Holdings - Intellectia AI
Casdin, Meister disclose sizable GeneDx (WGS) ownership positions - Stock Titan
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - The Chronicle-Journal
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 01 '26 |
Sale |
51.74 |
369 |
19,092 |
35,290 |
| Casdin Capital, LLC | Director |
May 19 '26 |
Buy |
42.60 |
185,000 |
7,880,334 |
3,367,164 |
| Casdin Capital, LLC | Director |
May 18 '26 |
Buy |
42.55 |
175,000 |
7,446,547 |
3,182,164 |
| Casdin Capital, LLC | Director |
May 20 '26 |
Buy |
43.81 |
140,000 |
6,132,854 |
3,507,164 |
| Meister Keith A. | Director |
May 13 '26 |
Buy |
39.09 |
165,000 |
6,449,983 |
4,598,297 |
| Meister Keith A. | Director |
May 14 '26 |
Buy |
39.39 |
140,000 |
5,514,790 |
4,738,297 |
| Meister Keith A. | Director |
May 15 '26 |
Buy |
38.91 |
46,273 |
1,800,571 |
4,784,570 |
| Meister Keith A. | Director |
May 07 '26 |
Buy |
37.86 |
533,758 |
20,207,189 |
3,761,908 |
| Meister Keith A. | Director |
May 11 '26 |
Buy |
39.29 |
500,000 |
19,642,789 |
4,433,297 |
| Meister Keith A. | Director |
May 08 '26 |
Buy |
40.59 |
171,389 |
6,956,751 |
3,933,297 |
2.13%
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):